Lazarus Jacob E, Green Chloe V, Jerry Michelle S, Germaine Lindsay, McEvoy Dustin S, Dugdale Caitlin M, Hysell Kristen M, Craig Rebecca L, Paras Molly L, Heller Howard M, Ard Kevin L, Albin John S, Lee Hang, Shenoy Erica S
Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Infect Control Hosp Epidemiol. 2024 Aug;45(8):1006-1008. doi: 10.1017/ice.2024.51. Epub 2024 Apr 2.
A clinical decision support system, EvalMpox, was developed to apply person under investigation (PUI) criteria for patients presenting with rash and to recommend testing for PUIs. Of 668 patients evaluated, an EvalMpox recommendation for testing had a positive predictive value of 35% and a negative predictive value of 99% for a positive mpox test.
开发了一种临床决策支持系统EvalMpox,用于对出现皮疹的患者应用疑似病例(PUI)标准,并为疑似病例推荐检测。在评估的668例患者中,EvalMpox的检测推荐对于猴痘检测呈阳性的阳性预测值为35%,阴性预测值为99%。